The FDA has approved the first blood test to help diagnose concussions, clearing a path to the market for a diagnostic that could reduce the use of expensive brain imaging technologies that expose patients to radiation.
The approval goes to San Diego diagnostics developer Banyan Biomarkers. The company’s test, called Banyan BTI (short for brain trauma indicator), measures the levels of two proteins that the brain releases into the blood in the hours following a head injury. The company developed the test with partial support from a contract with the U.S. Army.
The current standard for concussion diagnosis involves a neurological… Read more »
UNDERWRITERS AND PARTNERS